Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Accenture will acquire LabAnswer, a U.S.-based research and laboratory informatics technology consulting firm. Terms of the acquisition were not disclosed.
read more
Frontage Laboratories announced the completion of the acquisition of Teddy Clinical Research Laboratory, a clinical research laboratory service provider in China.
read more
Tuesday, November 30, 2021
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Dr Rory Curtis as Vice President US Commercial Operations. The appointment represents the next phase ...
read more
Rafael Pharmaceuticals, Inc. announced that it is changing its name to Cornerstone Pharmaceuticals, Inc. (“Cornerstone”), its original company name. All company branding, including the website and logo have been updated accordingly.
read more
Wednesday, September 22, 2021
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to ...
read more
AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million investment round financed by Epidarex Capital and CRT Pioneer Fund ('CPF').
read more
Highmark announced an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral medicine indicated to lower blood sugar in adults with type 2 diabetes.
read more
Avania, a full-service global MedTech contract research organization (“CRO”), announced that Astorg has acquired a majority stake in the company.
read more
Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director.
read more
Horizon Discovery Group announced its cGMP-compliant CHOSOURCE™ platform has played a key role in generating a stable cell line for the development of an immunotherapy for autoimmune diseases.
read more
OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s
continued compliance with Current Good Manufacturing Practices (cGMP), including quality
systems, ...
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced that WuXi Lab Testing Division (LTD)'s late-and commercial-stage analytical and ...
read more
Great Point Partners, an investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH (“Lyocontract”), a premium independent drug product contract development and manufacturing organization (“CDMO”) ...
read more
Monday, November 18, 2019
AGC Biologics announced their development and manufacturing capabilities at their Seattle, Washington and Copenhagen, Denmark facilities will be expanded.
read more
Eli Lilly has committed another 780,000 vials of insulin to the International Diabetes Federation's Life for a Child program.
read more